Clinical Trial Update: Study for Subjects With Relapsed/Refractory Non- Hodgkin Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating therapy for relapsed/refractory Non-Hodgkin lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Non Hodgkin's Lymphoma Refractory/Relapsed | Phase 1 | Status: RECRUITING